The U.S. Food and Drug Administration has published new consumer-facing guidance warning against the use of clear aligners purchased directly online without supervision from a licensed dentist or orthodontist. The announcement, publicized through ADA News on October 1, is one of the more consequential regulatory developments for general and orthodontic practices this fall.
What the FDA Said
The U.S. Food and Drug Administration is warning consumers about the risks of using unauthorized clear dental aligners sold directly to them without the supervision of a dentist or orthodontist. "The FDA has not authorized clear aligners that are marketed directly to consumers without supervision by a dentist or orthodontist," the agency said. "The lack of appropriate professional supervision may increase the risk of complications."
The agency drew a clear distinction between facility registration and formal product authorization: registration means a manufacturer has listed its facility and products with the agency while authorization means the FDA has reviewed the specific product and cleared or approved it for public use. That distinction matters because some mail-order aligner companies have implied regulatory approval that does not actually exist for unsupervised, direct-to-patient models.
Documented Patient Harm
The FDA said it has received reports involving unauthorized direct-to-consumer clear aligners in which patients experienced new or worsening dental pain, jaw pain, bite problems, worsening tooth misalignment and new gaps between teeth. The guidance does acknowledge a role for virtual care within a supervised plan, noting that some treatment plans may include remote monitoring and virtual dental visits, or teledentistry, however, it emphasized the role of in-person care in reducing potential complications.
Why This Matters Beyond Orthodontics
This update follows years of advocacy from the American Association of Orthodontists, which had compiled clinician-reported cases of complications tied to unsupervised mail-order treatment. For general dentists, the relevance goes beyond referral relationships — patients who started treatment through a DTC aligner company often show up first in a general practice with pain, bite changes, or loosened restorations, unaware that their treatment was never reviewed in person by a licensed provider.
What Practices Can Do Now
- Add a screening question to new-patient intake asking whether the patient is currently using, or has recently used, any mail-order orthodontic aligners.
- Document findings carefully if a patient presents with aligner-related complications so there is a clear record distinguishing supervised versus unsupervised treatment.
- Use the FDA's consumer page as a patient education resource when discussing the risks of unsupervised aligner therapy during exams or consults.
- Patients using clear aligners who develop new or worsening symptoms should contact their dentist or orthodontist for an evaluation, according to the agency — a message worth reinforcing in recall communications and office signage.
As direct-to-consumer dental and orthodontic products continue to market aggressively online, this FDA guidance gives practices a credible, authoritative resource to point to when counseling patients on the value of in-person, supervised care.